Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders (IAD)
Primary Purpose
Temporomandibular Disorder, Pain, Psychosocial Impairment
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Intra auricular device (IAD)
Sponsored by
About this trial
This is an interventional treatment trial for Temporomandibular Disorder focused on measuring Pressure Pain Threshold, Intra auricular device
Eligibility Criteria
Inclusion Criteria:
- age >18
- TMD-pain diagnosed according to the DC/TMD (myalgia, myofascial pain, arthralgia, headache attributable to TMD)
- disc displacement with reduction
Exclusion Criteria:
- disc displacement without reduction
- intermittent locking
- degenerative TMJ disorder
- craniofacial anomaly
- history of prior TMJ
- orthognathic surgery
- recent (within the past six months) trauma to the face or jaw
- current, active orthodontic treatment
- severe mental health disorder
Sites / Locations
- Donnarumma Valeria
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
TMD Pain group
Arm Description
Arm included patients with TMD Pain intensity >3 on a VAS scale and with diagnosis of myofascial pain, either alone or in combination with arthralgia, headache attributable to TMD or with disc displacement with reduction. Participants had to be 18 years of age or older. All subjects had to wear the device for 6 months and it should not be used for more than 23 hours in a 24-hour period
Outcomes
Primary Outcome Measures
Change of Pain (evaluated with Characteristic pain intensity scale)
This questionnaire is a valid instrument assessing pain intensity, numbers of days with interference and pain-related disability in the last month. The characteristic pain intensity score, which ranges from 0-100, is calculated as the mean intensity ratings for reported current, worst, and average pain
Change of Pain evaluated with instrumental exam( Pain Pressure Threshold)
Pain Pressure Threshold were assessed by a single examiner at the anterior temporalis and masseter muscles (respectively TdxM; TsxM; MdxM; MsxM). An additional measurement was performed at the right thenar muscle (TenM) selected as a control muscular site.
Psychosocial domain positive change
Evaluation of psychosocial positive change through psychosocial questionnaires.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05365932
Brief Title
Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders
Acronym
IAD
Official Title
Prospective Longitudinal Study for the Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
November 29, 2018 (Actual)
Primary Completion Date
May 8, 2019 (Actual)
Study Completion Date
December 10, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federico II University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background: An innovative, non-invasive, and reversible Intra Auricular Device (IAD) has recently been introduced to treat temporomandibular muscle and joint disorders.Aim: To evaluate the effects of the IAD on pain, psychosocial domain and Pressure Pain Threshold (PPT) of masticatory muscles in patients with TMD pain. Methods: Ten subjects with TMD pain and with pain intensity higher than 30 mm on a VAS scale were included in the study. Patients received the IAD and counselling. Assessments included questionnaires of the DC/TMD Axis II questionnaires (Characteristic Pain Index, Interference, Jaw Functional Limitation Scale, Patient Health Questionnaire 9, Patient Health Questionnaire 15, Generalized Anxiety Disorder scale, Oral Behavior Checklist and Oral Health Impact Profile-22, Axis I clinical examination and PPTs at baseline (T0), after one month (T1), three months (T2) and six months (T3) from the first use of the device. PPTs were measured at anterior temporalis muscles, masseter muscles and right thenar as a control site.The Shapiro-Wilk test was used for the normal distribution of data. The difference among the longitudinal timepoints for variable was analysed with ANOVA. Statistical significance was accepted at p < 0.05.
Detailed Description
The goal of ths study is to evaluate the effects of a new intra auricular device, the IAD, on pain, psychosocial domain and Pressure Pain Threshold (PPT) of facial muscles in patients with diagnosis of TMD pain according to the Diagnostic Criteria of Temporomandibular Disorders
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Temporomandibular Disorder, Pain, Psychosocial Impairment, Myofascial Pain
Keywords
Pressure Pain Threshold, Intra auricular device
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
TMD Pain group
Arm Type
Experimental
Arm Description
Arm included patients with TMD Pain intensity >3 on a VAS scale and with diagnosis of myofascial pain, either alone or in combination with arthralgia, headache attributable to TMD or with disc displacement with reduction. Participants had to be 18 years of age or older. All subjects had to wear the device for 6 months and it should not be used for more than 23 hours in a 24-hour period
Intervention Type
Device
Intervention Name(s)
Intra auricular device (IAD)
Intervention Description
The Intra Auricular Device (IADs) are a pair of inconspicuous, custom fit auricular prosthetic devices.The ear inserts are manufactured using computer-aided design/computer-aided manufacturing (CAD/CAM) technology and are made from a liquid, photo-reactive acrylate (EShell 300), used in hearing aid shells and otoplastics for the last 10 years. They are designed to be placed into the outer third of the ear canals, and they have a small retraction post used to facilitate removal . A red or blue dot, respectively, indicates the right and the left side. The device do not interfere with hearing or speech
Primary Outcome Measure Information:
Title
Change of Pain (evaluated with Characteristic pain intensity scale)
Description
This questionnaire is a valid instrument assessing pain intensity, numbers of days with interference and pain-related disability in the last month. The characteristic pain intensity score, which ranges from 0-100, is calculated as the mean intensity ratings for reported current, worst, and average pain
Time Frame
Six months from the first use of the device
Title
Change of Pain evaluated with instrumental exam( Pain Pressure Threshold)
Description
Pain Pressure Threshold were assessed by a single examiner at the anterior temporalis and masseter muscles (respectively TdxM; TsxM; MdxM; MsxM). An additional measurement was performed at the right thenar muscle (TenM) selected as a control muscular site.
Time Frame
Six months from the first use of the device
Title
Psychosocial domain positive change
Description
Evaluation of psychosocial positive change through psychosocial questionnaires.
Time Frame
Six months from the first use of the device
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age >18
TMD-pain diagnosed according to the DC/TMD (myalgia, myofascial pain, arthralgia, headache attributable to TMD)
disc displacement with reduction
Exclusion Criteria:
disc displacement without reduction
intermittent locking
degenerative TMJ disorder
craniofacial anomaly
history of prior TMJ
orthognathic surgery
recent (within the past six months) trauma to the face or jaw
current, active orthodontic treatment
severe mental health disorder
Facility Information:
Facility Name
Donnarumma Valeria
City
Afragola
ZIP/Postal Code
80021
Country
Italy
12. IPD Sharing Statement
Learn more about this trial
Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders
We'll reach out to this number within 24 hrs